Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Los Robles Hospital and Medical Center
Thousand Oaks, California, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Hematology Oncology Clinic, Llp
Baton Rouge, Louisiana, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- National Capital Clinical Research Consortium
Bethesda, Maryland, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Oncology Hematology Care Inc.
Cincinnati, Ohio, United States
- South Carolina Oncology Associates
Columbia, South Carolina, United States
- Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Leading Edge Research, Pa
Arlington, Texas, United States
- the Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
- Peninsula Cancer Institute
Newport News, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2010
- Primary completion
- 31 Aug 2015
- Completion
- 28 Feb 2017
- Last update posted
- 3 May 2017
- Registered enrollment
- 59
- Registry id
- NCT01056276
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.